Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention
Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention
About this item
Full title
Author / Creator
Publisher
Boston, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Boston, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Unfractionated heparin has been the standard anticoagulant used during percutaneous coronary intervention (PCI). In this trial, adjusted-dose unfractionated heparin was compared with enoxaparin in patients undergoing PCI. Enoxaparin significantly reduced the rate of major bleeding. The effect on prevention of coronary events was not definitively as...
Alternative Titles
Full title
Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_68838311
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68838311
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa052711
